A. Graham Pockley, PhD

A. Graham Pockley, PhD has extensive work experience in the biopharmaceutical industry and academia. A. Graham is currently serving as the Chief Executive Officer at multimmune GmbH, a clinical-stage biopharmaceutical company focused on developing innovative therapeutics and diagnostics for cancer treatment. A. Graham has been in this role since October 2015.

In addition, Dr. Pockley is the Chief Scientific Officer (Interim) and a Member of the Scientific Advisory Board at Alphageneron Pharmaceuticals, where they are involved in the development of targeted cancer therapeutics supported by a Companion Diagnostic. A. Graham started working at Alphageneron Pharmaceuticals in August 2021.

Dr. Pockley also serves as a Member of the Scientific Advisory Committee at Cytomos since January 2022.

Prior to their industry roles, Dr. Pockley held various positions at Nottingham Trent University. A. Graham was the Emeritus Professor of Immunobiology and Former Director & Professor of Immunobiology at the John van Geest Cancer Research Centre. Their research interests at the university focused on cancer biomarkers, disease progression monitoring, therapeutic responses prediction, and immunotherapy development. A. Graham held these positions from September 2016 to July 2022.

Before working at Nottingham Trent University, Dr. Pockley was an Honorary Professor at the University of Sheffield from May 2012 to May 2021. A. Graham has also held positions at the University of Sheffield as a Professor of Immunobiology, Reader in Immunobiology, and Lecturer in Immunobiology from October 1994 to April 2012.

Furthermore, Dr. Pockley has held academic positions at MEDICAL COLLEGE OF ST BARTHOLOMEW'S HOSPITAL & C as a Non-Clinical Lecturer in Transplantation Immunology from January 1991 to September 1994 and at Wayne State University School of Medicine as a Postdoctoral Research Associate in Mucosal Immunology from November 1988 to December 1990.

Dr. Pockley started their academic career as a Postgraduate Research Assistant in Reproductive Immunology (PhD) at Sheffield Hallam University from September 1985 to November 1988.

Aside from their academic and industry work, Dr. Pockley has also founded and served as the Chief Executive Officer of AGP Bio Limited, a company providing biopharmaceutical consulting services. A. Graham founded the company in November 2021. Additionally, they were the Founder & CEO of Chromocyte Limited, a company focused on serving the Flow Cytometry community with products and resources, from November 2009 to November 2021.

Overall, Dr. A. Graham Pockley has a diverse work experience in both industry and academia, with a focus on cancer research, immunobiology, and the development of innovative cancer therapeutics and diagnostics.

A. Graham Pockley, PhD, obtained their Bachelor of Science (Honors) degree in Biochemistry from The University of Sheffield, where they studied from 1979 to 1983. A. Graham then pursued their doctoral degree in Immunology (Reproductive) at Sheffield Hallam University, completing their PhD from 1985 to 1988. Prior to their university education, Pockley attended Hymers College from 1972 to 1979, although their specific degree and field of study during this period are not specified.